高视医疗获T3角膜共焦显微镜全球独家代理权(中国除外)

美股速递
Aug 17

高视医疗与Heidelberg达成重要合作,将出任T3角膜共焦显微镜在全球范围内的独家经销商,中国市场则不在此次合作范围内。这一协议的签署,标志着高视医疗在眼科医疗器械领域的布局进一步深化。根据双方达成的安排,高视医疗将全面负责T3角膜共焦显微镜在海外市场的推广、销售及服务支持,从而为全球眼科诊疗技术升级注入新动力。值得注意的是,此次独家代理权覆盖范围广泛,几乎囊括了全球所有国家和地区,唯独将中国大陆市场排除在外,这背后或许暗含了特定的市场策略或既有合作格局的考量。对于高视医疗而言,这一角色转换不仅是业务版图的拓展,更意味着其在国际眼科设备供应链中的地位将得到显著提升。未来,随着T3角膜共焦显微镜在全球更多医疗机构的落地应用,高视医疗有望借此契机强化自身在高端眼科设备领域的品牌影响力与市场渗透力。此次合作的具体财务条款尚未披露,但业界普遍认为,这将成为高视医疗全球化进程中的关键一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10